Compare PDEX & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDEX | EARN |
|---|---|---|
| Founded | 1978 | 2012 |
| Country | United States | United States |
| Employees | N/A | 160 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.2M | 181.1M |
| IPO Year | 1995 | 2012 |
| Metric | PDEX | EARN |
|---|---|---|
| Price | $58.62 | $4.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $56.00 | $5.38 |
| AVG Volume (30 Days) | 18.1K | ★ 400.5K |
| Earning Date | 05-01-2026 | 06-16-2026 |
| Dividend Yield | N/A | ★ 20.51% |
| EPS Growth | ★ 345.00 | N/A |
| EPS | ★ 3.27 | N/A |
| Revenue | ★ $66,593,000.00 | N/A |
| Revenue This Year | $7.22 | $7.69 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | $18.24 | ★ N/A |
| Revenue Growth | ★ 23.68 | N/A |
| 52 Week Low | $23.52 | $4.27 |
| 52 Week High | $61.62 | $6.08 |
| Indicator | PDEX | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 65.24 | 52.06 |
| Support Level | $37.15 | $4.54 |
| Resistance Level | $61.62 | $5.36 |
| Average True Range (ATR) | 3.10 | 0.09 |
| MACD | 0.45 | -0.00 |
| Stochastic Oscillator | 89.16 | 49.75 |
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.